TXNIP has been shown to promote GLUT1 and GLUT4 endocytosis and thus negatively regulate glucose uptake15,16, and TXNIP expression has been reported to be increased in muscles from individuals with impaired glucose tolerance or T2D14. The gene discussed is SLC2A4; the disease is Impaired glucose tolerance.